Rationale for combined therapies in severe-to-critical COVID-19 patients
Authors:
Open Access
- 11 September 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1232472
Abstract
An unprecedented global social and economic impact as well as a significant number of fatalities have been brought on by the coronavirus disease 2019 (COVID-19), produced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Acute SARS-CoV-2 infection can, in certain situations, cause immunological abnormalities, leading to an anomalous innate and adaptive immune response. While most patients only experience mild symptoms and recover without the need for mechanical ventilation, a substantial percentage of those who are affected develop severe respiratory illness, which can be fatal. The absence of effective therapies when disease progresses to a very severe condition coupled with the incomplete understanding of COVID-19’s pathogenesis triggers the need to develop innovative therapeutic approaches for patients at high risk of mortality. As a result, we investigate the potential contribution of promising combinatorial cell therapy to prevent death in critical patients.Keywords
This publication has 227 references indexed in Scilit:
- Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike ProteinViruses, 2012
- Immunomodulatory properties and therapeutic application of mesenchymal stem cellsClinical and Experimental Immunology, 2011
- Development of a Dose-Response Model for SARS CoronavirusRisk Analysis, 2010
- Viral evasion and subversion of pattern-recognition receptor signallingNature Reviews Immunology, 2008
- Angiotensin-Converting Enzyme Inhibition Improves Vascular Function in Rheumatoid ArthritisCirculation, 2008
- Induction of Apoptosis by the Severe Acute Respiratory Syndrome Coronavirus 7a Protein Is Dependent on Its Interaction with the Bcl-X L ProteinJournal of Virology, 2007
- Novel cell death program leads to neutrophil extracellular trapsJournal of Cell Biology, 2007
- Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells,Bone, 2003
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- Functional Role of Type I and Type II Interferons in Antiviral DefenseScience, 1994